000			03288nam a22005175i 4500
001			978-0-387-79838-7
003			DE-He213
005			20251006084422.0
007			cr nn 008mamaa
008			100301s2009 xxu| s |||| 0|eng d
020			_a9780387798387
020			_a99780387798387
024	7		_a10.1007/978-0-387-79838-7 _2doi
082	0	4	_a616.079 _223
100	1		_aFinn, Adam. _eeditor.
245	1	0	_aHot Topics in Infection and Immunity in Children V _h[electronic resource] / _cedited by Adam Finn, Nigel Curtis, Andrew J. Pollard.
264		1	_aNew York, NY : _bSpringer US, _c2009.
300			_bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aAdvances in Experimental Medicine and Biology, _x0065-2598 ; _v634
505	0		_aShiga-Toxin Producing Escherichia coli and the Hemolytic Uremic Syndrome: What Have We Learned in the Past 25 Years? -- Global Epidemiology of Pneumococcal Disease-New Prospects for Vaccine Control -- Current Concepts of the Pathogenesis of RSV Bronchiolitis -- How Can We Eradicate Pertussis -- Recognition and Management of Encephalitis in Children -- Microbiology and Management of Pleural Empyema -- Pneumococcal Conjugate Vaccines Probe Studies: The Solution Points to the Problem -- New Findings in Primary Immunodeficiency -- Routine Use of Influenza Vaccine -- Challenges in the Evaluation and Management of Bone and Joint Infections and the Role of New Antibiotics for Gram Positive Infections -- The Significance of Serotype Replacement for Pneumococcal Disease and Antibiotic Resistance -- Childhood Intra-thoracic Tuberculosis -- The Antibiotic Pipeline in Pediatrics -- Paediatric Drug Development and Clinical Trials -- Influenza in Pregnancy: The Case for Prevention -- Febrile Neutropenia in Children with Cancer -- The PANDAS Syndrome -- Fever in the Returned Paediatric Traveller -- Molecular Diagnostics of Primary Immunodeficiencies: Benefits and Future Challenges -- Human Genetic Resistance to Malaria.
520			_aCourse covers topics in infectious diseases in children and is intended for Pediatric Infectious disease trainees, trainers, and all those who manage children with infections. This conference is being supported by several societies and is sponsored by several pharmaceutical companies, such as Aventis, Baxter, Chiron Vaccines, Wyeth, etc.
650		0	_aMEDICINE.
650		0	_aIMMUNOLOGY.
650		0	_aMEDICAL VIROLOGY.
650		0	_aEMERGING INFECTIOUS DISEASES.
650		0	_aMICROBIOLOGY.
650	1	4	_aBIOMEDICINE.
650	2	4	_aIMMUNOLOGY.
650	2	4	_aVIROLOGY.
650	2	4	_aMICROBIOLOGY.
650	2	4	_aINFECTIOUS DISEASES.
700	1		_aCurtis, Nigel. _eeditor.
700	1		_aPollard, Andrew J. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9780387798370
830		0	_aAdvances in Experimental Medicine and Biology, _x0065-2598 ; _v634
856	4	0	_uhttp://dx.doi.org/10.1007/978-0-387-79838-7 _zVer el texto completo en las instalaciones del CICY
912			_aZDB-2-SBL
942			_2ddc _cER
999			_c59189 _d59189